Abstract: SA-PO1062
Cancer in Hemodialysis Patients
Session Information
- Hemodialysis and Frequent Dialysis - VI
November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Dialysis
- 701 Dialysis: Hemodialysis and Frequent Dialysis
Author
- Navarrete, Jose E., Emory University, Atlanta, Georgia, United States
Background
Describe the incidence of cancer in hemodialysis patients. Describe the most common types of cancer in hemodialysis patients.
Methods
Incident hemodialysis patients enrolled in the Emory Dialysis program form 1/2011 to 12/2015 were followed until the diagnosis of cancer, death or censoring up to 12/31/2018. Time from inititation of dialysis to diagnosis of cancer and type of cancer was recorded.
Results
902 patients were enrrolled in the hemodialysis program. 25 (2.8%) patients with prior cancer were excluded from the analysis as well as 51 patients followed less than a month. The remaining 826 patients are the base of this report. 51 patients (6.2%) developed a new cancer. Cancer patients were older (65 vs 57). The cumulative risk of cancer is presented in figure 1 (11%). The most common cancers were urological (20%), paraproteinemia (20%), prostate (17%), gastrointestinal (8%), lung (8%), breast (6%), gynecological (6%), liver (4%), skin (4%) and brain, adrenals and unknown primary with 1% (Figure 2)
Conclusion
The cumulative risk of cancer was 11% over 8 years. Cancer patients were older and had a lower hemoglobin. Urological, paraproteinemias and other solid organ cancers represent the majority of cancer diagnosed and this information could be used to delineate strategies for early detection of cancer in hemodialysis patients.